Heidi S. Harvie, MD, MBA, MSCE
she/her/hers
Urogynecology
Accepting new patients
Sees patients age 18 and up
Penn Urogynecology Washington Square
Make an appointmentCall 800-789-7366
Penn Medicine Provider

About me

  • Director, Penn Urogynecology & Pelvic Reconstructive Surgery, Pennsylvania Hospital
  • Associate Professor of Obstetrics and Gynecology at the Pennsylvania Hospital

Education and training

  • Medical School: University of Pennsylvania School of Medicine
  • Residency: University of Pennsylvania Health System
  • Fellowship: University of Pennsylvania Health System

What my patients think about me

Average Rating

433 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

November 2025
dr.harvie is a awesome lady
November 2025
i fully trust dr harvie's recommendations & skills for the medical issues i was having; she's an excellent surgeon & explained the procedure i had done & answered all questions i had! i would definitely recommend her to any female suffering from similar conditions.
November 2025
my surgery experience was exceptional and dr Harvie patient interaction is wonderful. she explained everything and answers all questions in detail. she gained my confidence and the results are phenomenal.
October 2025
she is a great doctor

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Harvie is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Muñoz JM, Kim EK, Andy UU, Mumford SL, Harvie HS Variation in Overactive Bladder Treatment Type by Social Determinants of Health. , Urogynecology, 31(10): 2025,929-941

Harvie HS, Chermansky C, Richter HE Midurethral Sling vs OnabotulinumtoxinA for Urinary Incontinence-Reply , JAMA: 2025

Walter JR, Richards EG, Johannesson L, Falcone T, Testa G, O'Neill KE, Harvie HS Cost-effectiveness Analysis of Uterus Transplantation versus Gestational Carrier for Treatment of Absolute Uterine Factor Infertility. , Fertil Steril, 124(1): 2025,121-133

Reaves S, Levin, PJ, Harvie HS, Andy UU Factors Affecting Follow-up for Specialty Postpartum Care after Obstetric Anal Sphincter Injury at a Single U.S. Institution. , Int Urogynecol J, 36(7): 2025,1457-1463

Harvie HS, Menefee SA, Richter HE, Sung VW, Chermansky CJ, Rahn DD, Amundsen CL, Arya LA, Rhodes E, Mazloomdoost D, Thomas S, National Institute of Child Health and Human Development Pelvic Floor Disorders Network Midurethral Sling vs OnabotulinumtoxinA in Females With Urinary Incontinence: The MUSA Randomized Clinical Trial. , JAMA, 333(21): 2025,1887-1896

Arya LA, Agrawal S, Ikpeama N, Harvie H, Feldman RH, Dutcher L Implementing a Digital Platform for Recurrent Urinary Tract Infection , Urogynecology, 31(3): 2025,183-193

Arya LA, Agrawal S, Ikpeama N, Harvie HS, Feldman RH, Dutcher L Implementing a Digital Platform for Recurrent Urinary Tract Infections. , Urogynecology , 31(3): 2025,183-193

CX Hong, M O'Leary, W Horner, PC Schmidt, HS Harvie, NS Kamdar, DM Morgan Decreasing Utilization of Vaginal Hysterectomy in the United States: An Analysis by Candidacy for Vaginal Approach , Int Urogynecol J, 35(10): 2024,1983-1991

Gleason E, Andriani L, Tubridy EA, Uwawuike D, Gunter S, Koelper NC, Harvie HS, Ko EM Cost of care associated with utilization of telehealth in clinical trials. , Gynecol Oncol Rep, 56: 2024,101523

Kreines FM, Cox CK, Mumford SL, Harvie HS, Arya LA, Andy UU Validation of Lower Urinary Tract Symptom Questionnaire in the Transmasculine Population , Int Urogynecol J, 35(9): 2024,1881-1887.